Reduced malignant glioblastoma recurrence post-resection through the anti-CD47 antibody and Temozolomide co-embedded in-situ hydrogel system

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text

Medicine, Oncology, Radiation Oncology +12

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

Mark R. Gilbert, James J. Dignam, Terri S. Armstrong et al. · New England Journal of Medicine · 2014 · 2.8K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Role of CD47 as a Marker of Self on Red Blood Cells

Per‐Arne Oldenborg, Alex Zheleznyak, Yifu Fang et al. · Science · 2000 · 1.9K citations

Life Sciences, Cell Biology, Immunology +17

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Stephen B. Willingham, Jens-Peter Volkmer, Andrew J. Gentles et al. · Proceedings of the National Academy of Sciences · 2012 · 1.7K citations · Full text

Medicine, Immunology, Oncology +17

CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis

Siddhartha Jaiswal, Catriona Jamieson, Wendy W. Pang et al. · Cell · 2009 · 1.6K citations

Medicine, Cell Biology, Hematology +10